Auricular leishmaniasis in a child successfully treated with intralesional amphotericin B

Andrea Diociaiuti; Simona Giancristoforo; Francesca Ippolita Calò Carducci; Claudia Bracaglia; Alessandra Boni; Stefania Pane; Andrea Onetti Muda; Fabrizio De Benedetti; Lorenza Putignani; May El Hachem

doi:10.1111/pde.15046

Auricular leishmaniasis in a child successfully treated with intralesional amphotericin B

Pediatr Dermatol. 2022 Sep;39(5):832-833. doi: 10.1111/pde.15046. Epub 2022 Jun 11.

Affiliations

¹ Dermatology Unit and Genodermatosis Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
² Unit of Infectious Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
³ Unit of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
⁴ Unit of Parasitology, Department of Diagnostic and Laboratory Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
⁵ Department of Diagnostic and Laboratory Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
⁶ Unit of Parasitology and Multimodal Laboratory Medicine Research Area, Unit of Human Microbiome, Department of Diagnostic and Laboratory Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Abstract

Cutaneous leishmaniasis (CL) is the most frequent form of leishmaniasis. The auricle is an extremely rare site for CL in the Old World. Auricular CL may be mistaken for other entities, such as relapsing polychondritis (RP). Here we report a pediatric case of Old World auricular CL mimicking RP in a child successfully treated with intralesional liposomal amphotericin B.

Keywords: Old World leishmaniasis; auricular leishmaniasis; child; cutaneous leishmaniasis; intralesional amphotericin B.

Publication types

Case Reports

MeSH terms

Amphotericin B / therapeutic use
Antiprotozoal Agents* / therapeutic use
Child
Ear Auricle*
Family
Humans
Leishmaniasis, Cutaneous* / diagnosis
Leishmaniasis, Cutaneous* / drug therapy

Substances

Antiprotozoal Agents
Amphotericin B